Trials / Unknown
UnknownNCT02305966
Evaluation of Implant Fixation in Reverse Total Shoulder Arthroplasty
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Reverse total shoulder replacement surgery (RTSA) is performed for individuals with advanced arthritis of the shoulder who also have tears in their rotator cuff muscles. A metal hemisphere is placed in the shoulder blade, and a plastic cup on a stem is placed in the upper arm. This orientation is opposite to the normal anatomy, giving rise to the term "reverse" shoulder replacement. While RTSA has a good clinical track record, no studies have examined how well fixed the implanted components are within patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | surgery | All patients will receive a Delta XTEND reverse shoulder implant |
| DEVICE | 0.8 mm diameter Tantalum marker beads | At the time of surgery, 0.8 mm diameter Tantalum marker beads will be injected into the bone surrounding the implant, |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2018-12-01
- Completion
- 2019-11-01
- First posted
- 2014-12-03
- Last updated
- 2017-03-24
Source: ClinicalTrials.gov record NCT02305966. Inclusion in this directory is not an endorsement.